GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Synonyms: AB 103 | AB103 | p2TA
Compound class:
Peptide
Comment: Reltecimod is a mimetic peptide that prevents binding of bacterial superantigens to the host target of CD28 [1]. It entered clinical development as an immunomodulating agent, with the aim of reducing the acute inflammatory response observed in patients with necrotizing soft tissue infections (NSTIs) that can lead to organ failure [2-3].
|
|
Classification ![]() |
|
Compound class | Peptide |
International Nonproprietary Names ![]() |
|
INN number | INN |
10377 | reltecimod |
Synonyms ![]() |
AB 103 | AB103 | p2TA |
Database Links ![]() |
|
Specialist databases | |
Antibiotic DB
![]() |
Reltecimod |
Other databases | |
CAS Registry No. | 1447799-33-8 (source: Scifinder) |
ChEMBL Ligand | CHEMBL3989950 |
DrugBank Ligand | DB16687 |
GtoPdb PubChem SID | 507750355 |
PubChem CID | 71652162 |
Search Google for chemical match using the InChIKey | VRNHFZYMPDKTBS-WYUJEMNCSA-N |
Search Google for chemicals with the same backbone | VRNHFZYMPDKTBS |
Search PubMed clinical trials | reltecimod |
Search PubMed titles | reltecimod |
Search PubMed titles/abstracts | reltecimod |
UniChem Compound Search for chemical match using the InChIKey | VRNHFZYMPDKTBS-WYUJEMNCSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | VRNHFZYMPDKTBS-WYUJEMNCSA-N |